Can magnetic brain stimulation lift Long-COVID brain fog?
NCT ID NCT06586398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study tests whether repetitive transcranial magnetic stimulation (rTMS) can ease fatigue, brain fog, and other neuropsychiatric symptoms in people with Long-COVID. Ten participants will first receive either active or sham rTMS for 15 sessions, then all will get active treatment for another 15 sessions. The goal is to check safety and gather early data on symptom changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
repetitive transcranial magnetic stimulation (rTMS)
What this could lead to
If it works, this could point toward a non-drug treatment for fatigue and brain fog in Long-COVID.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply widely. It is too early to know if rTMS truly helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA Semel Institute
Los Angeles, California, 90095, United States